Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- William B Slayton
Children's Oncology Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
134 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Brisbane and Women'S Hospital
Herston, Queensland, Australia
- Royal Children'S Hospital-Brisbane
Herston, Queensland, Australia
- Women'S and Children'S Hospital-Adelaide
North Adelaide, South Australia, Australia
- Princess Margaret Hospital for Children
Perth, Western Australia, Australia
- British Columbia Children'S Hospital
Vancouver, British Columbia, Canada
- Cancercare Manitoba
Winnipeg, Manitoba, Canada
- Iwk Health Centre
Halifax, Nova Scotia, Canada
- Mcmaster Children'S Hospital at Hamilton Health Sciences
Hamilton, Ontario, Canada
- Hospital for Sick Children
Toronto, Ontario, Canada
- Centre Hospitalier Universitaire Sainte-Justine
Montreal, Quebec, Canada
- the Montreal Children'S Hospital of the Muhc
Montreal, Quebec, Canada
- Saskatoon Cancer Centre
Saskatoon, Saskatchewan, Canada
- Centre Hospitalier Universitaire de Quebec
Québec, Canada
- Starship Children'S Hospital
Grafton, Auckland, New Zealand
- Christchurch Hospital
Christchurch, New Zealand
- San Jorge Children'S Hospital
San Juan, Puerto Rico
- Children'S Hospital of Alabama
Birmingham, Alabama, United States
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Phoenix Childrens Hospital
Phoenix, Arizona, United States
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Kaiser Permanente Downey Medical Center
Downey, California, United States
- Miller Children'S and Women'S Hospital Long Beach
Long Beach, California, United States
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Mattel Children'S Hospital Ucla
Los Angeles, California, United States
- Ucla / Jonsson Comprehensive Cancer Center
Los Angeles, California, United States
- Valley Children'S Hospital
Madera, California, United States
- Kaiser Permanente-Oakland
Oakland, California, United States
- Children'S Hospital of Orange County
Orange, California, United States
- Lucile Packard Children'S Hospital Stanford University
Palo Alto, California, United States
- Rady Children'S Hospital - San Diego
San Diego, California, United States
- Ucsf Medical Center-Mount Zion
San Francisco, California, United States
- Ucsf Medical Center-Parnassus
San Francisco, California, United States
- Harbor-University of California at Los Angeles Medical Center
Torrance, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- University of Connecticut
Farmington, Connecticut, United States
- Connecticut Children'S Medical Center
Hartford, Connecticut, United States
- Yale University
New Haven, Connecticut, United States
- Alfred I Dupont Hospital for Children
Wilmington, Delaware, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Jul 2008
- Primary completion
- 31 Dec 2014
- Completion
- 31 Mar 2020
- Last update posted
- 13 Apr 2020
- Registered enrollment
- 63
- Registry id
- NCT00720109
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.